Five Prime Therapeutics, Inc. Appoints Aron Knickerbocker to Its Board of Directors and Marc Belsky to Chief Financial Officer
Published: Oct 24, 2013
SOUTH SAN FRANCISCO, Calif., Oct. 23, 2013 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced the appointment of Aron Knickerbocker, Senior Vice President and Chief Business Officer of Five Prime, to the company's Board of Directors and the appointment of Marc Belsky to the position of Chief Financial Officer.
Help employers find you! Check out all the jobs and post your resume.